Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Phil Frohlich, Prescott Group Ask For PharmAthene Shareholder Meeting

PharmAthene, Prescott Group Capital Management: After Phil Frohlich, manager of Prescott Group Capital Management, disclosed his ownership of 10% of PharmAthene, Inc. (NYSEMKT:PIP) a couple weeks back, now he’s requested that the company call a special shareholder meeting for November 1. The scope of the meeting is adopting two resolutions in relation to PharmAthene’s civil actions against SIGA Technologies, and some general business matters.

Pharmathene

The whole text of the letter sent by Frochlich to PharmAthene can be read through accessing the link below.

Prescott Group Capital Management Letter to PharmAthene

Earlier in May, the Delaware Supreme Court confirmed an earlier decision that SIGA Technologies broke its contractual obligation to negatiate in good faith. The case has been remanded to the Delaware Court of Chancery for reconsideration of the damages award, consistent with the Supreme Court’s opinion, PharmAthene said in a statement.

Benjamin J Taylor‘s  Sophrosyne Capital is also a shareholder of PharmAthene with a stake of 804,902 shares reported at the end of the second quarter.

Disclosure: none

Recommended Reading:

Icahn Gets Key Board Appointment at Enzon Pharmaceuticals

Lazard Asset Management Loves SJW Corp

Is This the End of Steven Cohen’s Insider Trading Battle?

Loading...